From a Forbes US site (originally mentioned on a Progen board on Yahoo) - Genentech's Avistan predicted to be a blockbuster seller. Progen's PI-88 is possibly more effective with multiple modes of action.
No wonder PGL's SP is taking off. PI-88 could be commercialised in 2006.
http://www.forbes.com/home/markets/2004/10/08/1008automarketscan10.html
From a Forbes US site (originally mentioned on a Progen board on...
Add to My Watchlist
What is My Watchlist?